Clinical Trial Update: Stem Cell Gene Therapy for Sickle Cell Disease [Phase 1, Phase 2]

View source ↗

Summary

An update on a Phase 1/Phase 2 stem cell gene therapy trial for sickle cell disease led by Donald B. Kohn; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: Donald B. Kohn, M.D. | Conditions: Sickle Cell Disease | Phase 1, Phase 2 | Status: COMPLETED